DECREASED CYTOCHROME-C-OXIDASE ACTIVITY AND LACK OF AGE-RELATED ACCUMULATION OF MITOCHONDRIAL-DNA DELETIONS IN THE BRAINS OF SCHIZOPHRENICS

被引:137
作者
CAVELIER, L
JAZIN, EE
ERIKSSON, I
PRINCE, J
BAVE, U
ORELAND, L
GYLLENSTEN, U
机构
[1] UNIV UPPSALA, DEPT MED GENET, S-75123 UPPSALA, SWEDEN
[2] UNIV UPPSALA, DEPT MED PHARMACOL, S-75123 UPPSALA, SWEDEN
关键词
D O I
10.1006/geno.1995.1234
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Defects in mitochondrial energy production have been implicated in several neurodegenerative disorders, such as Parkinson disease and amyotrophic lateral sclerosis. To study the contribution of mitochondrial defects to Alzheimer disease and schizophrenia, cytochrome-c oxidase (COX) activity and levels of the mtDNA(4977) deletion in postmortem brain tissue specimens of patients were compared with those of asymptomatic age-matched controls. No difference in COX activity was observed between Alzheimer patients and controls in any of five brain regions investigated. In contrast, schizophrenic patients had a 63% reduction of the COX activity in the nucleus caudatus (P<0.0001) and a 43% reduction in the cortex gyrus frontalis (P<0.05) as compared to controls. The average levels of the mtDNA(4977) deletion did not differ significantly between Alzheimer patients and controls, and the deletion followed similar modes of accumulation with age in the two groups. In contrast, no age-related accumulation of mtDNA deletions was found in schizophrenic patients. The reduction in COX activity in schizophrenic patients did not correlate with changes in the total amount of mtDNA or levels of the mtDNA(4977) deletion. The lack of age-related accumulation of the mtDNA(4977) deletion and reduction in COX activity suggest that a mitochondrial dysfunction may be involved in the pathogenesis of schizophrenia. (C) 1995 Academic Press, Inc.
引用
收藏
页码:217 / 224
页数:8
相关论文
共 40 条
  • [1] GENES FOR NORMAL AND DISEASED MENTAL STATES
    ASHALL, F
    [J]. TRENDS IN GENETICS, 1994, 10 (02) : 37 - 39
  • [2] CDNA CLONING OF HUMAN-LIVER MONOAMINE OXIDASE-A AND OXIDASE-B - MOLECULAR-BASIS OF DIFFERENCES IN ENZYMATIC-PROPERTIES
    BACH, AWJ
    LAN, NC
    JOHNSON, DL
    ABELL, CW
    BEMBENEK, ME
    KWAN, SW
    SEEBURG, PH
    SHIH, JC
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (13) : 4934 - 4938
  • [3] DO DEFECTS IN MITOCHONDRIAL ENERGY-METABOLISM UNDERLIE THE PATHOLOGY OF NEURODEGENERATIVE DISEASES
    BEAL, MF
    HYMAN, BT
    KOROSHETZ, W
    [J]. TRENDS IN NEUROSCIENCES, 1993, 16 (04) : 125 - 131
  • [4] RESPIRATORY-CHAIN ABNORMALITIES IN SKELETAL-MUSCLE FROM PATIENTS WITH PARKINSONS-DISEASE
    BINDOFF, LA
    BIRCHMACHIN, MA
    CARTLIDGE, NEF
    PARKER, WD
    TURNBULL, DM
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1991, 104 (02) : 203 - 208
  • [5] MITOCHONDRIAL-FUNCTION IN PARKINSONS-DISEASE
    BINDOFF, LA
    BIRCHMACHIN, M
    CARTLIDGE, NEF
    PARKER, WD
    TURNBULL, DM
    [J]. LANCET, 1989, 2 (8653) : 49 - 49
  • [6] MUSCLE BIOPSY FINDINGS, CONDUCTION-VELOCITY AND REFRACTORY PERIOD OF SINGLE MOTOR-NERVE FIBERS IN SCHIZOPHRENIA
    BORG, J
    EDSTROM, L
    BJERKENSTEDT, L
    WIESEL, FA
    FARDE, L
    HAGENFELDT, L
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1987, 50 (12) : 1655 - 1664
  • [7] NEUROLEPTIC MEDICATIONS INHIBIT COMPLEX-I OF THE ELECTRON-TRANSPORT CHAIN
    BURKHARDT, C
    KELLY, JP
    LIM, YH
    FILLEY, CM
    PARKER, WD
    [J]. ANNALS OF NEUROLOGY, 1993, 33 (05) : 512 - 517
  • [8] INTERACTIONS BETWEEN GLUTAMATERGIC AND MONOAMINERGIC SYSTEMS WITHIN THE BASAL GANGLIA - IMPLICATIONS FOR SCHIZOPHRENIA AND PARKINSONS-DISEASE
    CARLSSON, M
    CARLSSON, A
    [J]. TRENDS IN NEUROSCIENCES, 1990, 13 (07) : 272 - 276
  • [9] IMPAIRMENT IN MITOCHONDRIAL CYTOCHROME-OXIDASE GENE-EXPRESSION IN ALZHEIMER-DISEASE
    CHANDRASEKARAN, K
    GIORDANO, T
    BRADY, DR
    STOLL, J
    MARTIN, LJ
    RAPOPORT, SI
    [J]. MOLECULAR BRAIN RESEARCH, 1994, 24 (1-4): : 336 - 340
  • [10] MITOCHONDRIAL-FUNCTION IN ALZHEIMERS-DISEASE
    COOPER, JM
    WISCHIK, C
    SCHAPIRA, AHV
    [J]. LANCET, 1993, 341 (8850) : 969 - 970